PATENT CLAIM ANALYSIS

Application Number: 15764247
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "474000"]

Abstract:
The invention relates to pharmaceutical compositions comprising 6-thioguanidine (6-TG) wherein the composition is formulated for release of 6-TG in the distal intestine. Methods for treating a disease or condition of the distal ileum that responds to 6-TG wherein the 6-TG is released in the distal intestine are also disclosed.

Claim (Index 17):
A method according to  claim 15  wherein the 6-TG is metabolised by luminal bacteria or diseased mucosa at a site of inflammation associated with the inflammation bowel disease.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 90.0
- Lexical Diversity: 1.47222
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14407780', '14890131', '15439733', '12647348', '13688193']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.741865121809936
- 35 USC 102 Novelty (BERT): 0.5152118965148182
- Combined Prediction Score: 0.7191997992804242
- Mean Citation Score: 247.96281800000003
- Max Citation Score: 260.50232
- Similarity Product: 155.34949086044313

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test